Scotland tests the waters with new troponin policy
This article was originally published in Clinica
Scottish hospitals may soon be providing troponin testing - if draft recommendations by the Health Technology Board for Scotland (HTBS) are approved. The consultation assessment report published this week recommends that the technology be made available at every hospital that receives patients with suspected acute coronary syndromes.
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.